Bartering Your Eggs: A Rotten Deal
By Arthur Caplan and Gwendolyn P. Quinn,
Hastings Bioethics Forum
| 08. 17. 2023
The technology associated with assisted reproduction has grown exponentially in the last two decades. Planned oocyte and sperm freezing, posthumous reproductive genetic testing, and egg and donor sperm brokering are expanding infertility services. Demand has grown, as well. Estimates suggest there are now over one million donor-conceived children, about 10,000 per year. The use of donor gametes has allowed people with infertility or other medical conditions to achieve their parenthood goals.
The settings in which services are delivered are rapidly evolving, too. What was once only offered by academic and private medical facilities has become a burgeoning platform for start-ups, private equity firms, and international entrepreneurs. Corporations are offering insurance coverage for egg freezing for their young female employees. Around the country, egg freezing and egg shower parties market services to women. There are approximately 1,500 sperm banks and around 1,900 egg banks across the world with profits for sperm banks estimated at over $4 million in 2019 and for egg banks $487 million in the U.S. alone.
However, there is significant reproductive injustice and lack of access...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...